Year: 2016
Type: review
Abstract: Infections occur frequently in critically ill patients and their management can be challenging for various reasons, including delayed diagnosis, difficulties identifying causative microorganisms, and the high prevalence of antibiotic-resistant strains. In this review, we briefly discuss the importance of early infection diagnosis, before considering in more detail some of the key issues related to antibiotic management in these patients, including controversies surrounding use of combination or monotherapy, duration of therapy, and de-escalation. Antibiotic pharmacodynamics and pharmacokinetics, notably volumes of distribution and clearance, can be altered by critical illness and can influence dosing regimens. Dosing decisions in different subgroups of patients, e.g., the obese, are also covered. We also briefly consider ventilator-associated pneumonia and the role of inhaled antibiotics. Finally, we mention antibiotics that are currently being developed and show promise for the future.
Source: Critical Care
Institutions: Université Libre de Bruxelles, Erasmus Hospital, Ospedale Santa Maria della Misericordia di Udine, Centre Hospitalier Universitaire de Limoges, Hôpital Universitaire Dupuytren, Louisiana State University, Louisiana State University Health Sciences Center New Orleans, Pitié-Salpêtrière Hospital, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, The University of Queensland, Royal Brisbane and Women's Hospital, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Centre Hospitalier Interrégional Edith Cavell, Medizinische Hochschule Hannover, Agostino Gemelli University Polyclinic
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: antibiotic therapy, critically ill patients, sepsis, early infection detection, antibiotic resistance, combination therapy, monotherapy, antibiotic duration, antibiotic de-escalation, pharmacokinetics, pharmacodynamics, obesity, ventilator-associated pneumonia, inhaled antibiotics, novel antibiotics
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W2345430760
